File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Book Chapter: Anti-Obesity Drugs for Obese Women Planning Pregnancy

TitleAnti-Obesity Drugs for Obese Women Planning Pregnancy
Authors
Li, RHWLee, CPLam, KSLHo, PC
KeywordsAnti-obesity drugs
pre-pregnancy
orlistat
metformin
sibutramine
Issue Date2012
PublisherElsevier
Citation
Anti-Obesity Drugs for Obese Women Planning Pregnancy. In Mahmood, TA & Arulkumaran, S (Eds.), Obesity: a Ticking Time Bomb for Reproductive Health , p. 423-430. London; Waltham, MA : Elsevier, 2012 How to Cite?
DOI: http://dx.doi.org/10.1016/B978-0-12-416045-3.00031-5
AbstractObesity remains an important risk factor for women planning for pregnancy because of its adverse effects on reproductive outcome. In individuals who experience difficulty in reducing significant weight with lifestyle intervention alone, the use of anti-obesity drugs can be an adjunct. Orlistat and metformin are the options currently, and their use is probably safe for women planning for pregnancy. These weight loss interventions should precede any planned conception or fertility treatment.
Persistent Identifierhttp://hdl.handle.net/10722/201930
ISBN
9780124160453

 

DC FieldValueLanguage
dc.contributor.authorLi, RHWen_US
dc.contributor.authorLee, CPen_US
dc.contributor.authorLam, KSLen_US
dc.contributor.authorHo, PCen_US
dc.date.accessioned2014-08-21T07:50:01Z-
dc.date.available2014-08-21T07:50:01Z-
dc.date.issued2012en_US
dc.identifier.citationAnti-Obesity Drugs for Obese Women Planning Pregnancy. In Mahmood, TA & Arulkumaran, S (Eds.), Obesity: a Ticking Time Bomb for Reproductive Health , p. 423-430. London; Waltham, MA : Elsevier, 2012en_US
dc.identifier.isbn9780124160453en_US
dc.identifier.urihttp://hdl.handle.net/10722/201930-
dc.description.abstractObesity remains an important risk factor for women planning for pregnancy because of its adverse effects on reproductive outcome. In individuals who experience difficulty in reducing significant weight with lifestyle intervention alone, the use of anti-obesity drugs can be an adjunct. Orlistat and metformin are the options currently, and their use is probably safe for women planning for pregnancy. These weight loss interventions should precede any planned conception or fertility treatment.-
dc.languageengen_US
dc.publisherElsevier-
dc.relation.ispartofObesity: a Ticking Time Bomb for Reproductive Healthen_US
dc.subjectAnti-obesity drugs-
dc.subjectpre-pregnancy-
dc.subjectorlistat-
dc.subjectmetformin-
dc.subjectsibutramine-
dc.titleAnti-Obesity Drugs for Obese Women Planning Pregnancyen_US
dc.typeBook_Chapteren_US
dc.identifier.emailLi, RHW: raymondli@hku.hken_US
dc.identifier.emailLee, CP: chinpeng@hkucc.hku.hken_US
dc.identifier.emailLam, KSL: ksllam@hku.hken_US
dc.identifier.emailHo, PC: pcho@hku.hken_US
dc.identifier.authorityLi, RHW=rp01649en_US
dc.identifier.authorityLee, CP=rp01862en_US
dc.identifier.authorityLam, KSL=rp00343en_US
dc.identifier.authorityHo, PC=rp00325en_US
dc.identifier.doi10.1016/B978-0-12-416045-3.00031-5-
dc.identifier.scopuseid_2-s2.0-84884013334-
dc.identifier.hkuros234758en_US
dc.identifier.spage423en_US
dc.identifier.epage430en_US
dc.publisher.placeLondon; Waltham, MA-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats